Cargando…

Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey

BACKGROUND: In order to assess the level of transmitted and/or pre-treatment antiretroviral drug resistance to HIV-1, the World Health Organization (WHO) recommends that regular surveys are conducted. This study’s objective was to assess the frequency of HIV-1 antiretroviral drug resistance in patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steegen, Kim, Carmona, Sergio, Bronze, Michelle, Papathanasopoulos, Maria A., van Zyl, Gert, Goedhals, Dominique, MacLeod, William, Sanne, Ian, Stevens, Wendy S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132262/ https://www.ncbi.nlm.nih.gov/pubmed/27907009 http://dx.doi.org/10.1371/journal.pone.0166305

Ejemplares similares

High-Level Cross-Resistance to Didanosine Observed in South African Children Failing an Abacavir- or Stavudine-Based 1(st)-Line Regimen
por: Steegen, Kim, et al.
Publicado: (2014)

High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa
por: Skhosana, Lindiwe, et al.
Publicado: (2015)

PhyloPi: An affordable, purpose built phylogenetic pipeline for the HIV drug resistance testing facility
por: Bester, Phillip Armand, et al.
Publicado: (2019)

Resistance in Patients Failing Integrase Strand Transfer Inhibitors: A Call to Replace Raltegravir With Dolutegravir in Third-Line Treatment in South Africa
por: Steegen, Kim, et al.
Publicado: (2019)

Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study
por: Maskew, Mhairi, et al.
Publicado: (2017)

CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data
por: Kufa, Tendesayi, et al.
Publicado: (2019)

Cohort profile: the South African National Health Laboratory Service (NHLS) National HIV Cohort
por: MacLeod, William B, et al.
Publicado: (2022)

HIV-1 Phenotypic Reverse Transcriptase Inhibitor Drug Resistance Test Interpretation Is Not Dependent on the Subtype of the Virus Backbone
por: Bronze, Michelle, et al.
Publicado: (2012)

Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa
por: Fox, Matthew P., et al.
Publicado: (2018)

Human papillomavirus in head and neck squamous cell carcinomas in a South African cohort
por: Sekee, Tumelo R., et al.
Publicado: (2018)

Correction: Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa
por: Fox, Matthew P., et al.
Publicado: (2018)

Low Prevalence of Liver Disease but Regional Differences in HBV Treatment Characteristics Mark HIV/HBV Co-Infection in a South African HIV Clinical Trial
por: Ive, Prudence, et al.
Publicado: (2013)

Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes
por: Moorhouse, Michelle, et al.
Publicado: (2019)

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens
por: Van Zyl, Gert U., et al.
Publicado: (2013)

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
por: Schnippel, Kathryn, et al.
Publicado: (2012)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
por: Moorhouse, Michelle A., et al.
Publicado: (2018)

African trypanosomiasis
por: Morrison, L J, et al.
Publicado: (2011)

Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory
por: Hans, Lucia, et al.
Publicado: (2021)

Changing the South African national antiretroviral therapy guidelines: The role of cost modelling
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Product visibility in the South African citrus cold chain: Examining the efficacy of temperature loggers
por: Khumalo, Gculisile, et al.
Publicado: (2022)

High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study
por: Innes, Steve, et al.
Publicado: (2012)

Low-level viraemia despite emergence of dolutegravir-resistant variants
por: Botha, Johannes C., et al.
Publicado: (2022)

Adult antiretroviral therapy guidelines 2017
por: Meintjes, Graeme, et al.
Publicado: (2017)

Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa
por: Steegen, Kim, et al.
Publicado: (2021)

Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa
por: Wallis, Carole L., et al.
Publicado: (2011)

Referential focus moderates depression-linked attentional avoidance of positive information
por: Ji, Julie Lin, et al.
Publicado: (2017)

Antiretroviral Outcomes in South African Prisoners: A Retrospective Cohort Analysis
por: Davies, Natasha E. C. G., et al.
Publicado: (2012)

Understanding patients reinitiating antiretroviral therapy in two South African districts
por: Rees, Kate, et al.
Publicado: (2022)

Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment
por: Knight, Marlene, et al.
Publicado: (2015)

An Update on African Trypanocide Pharmaceutics and Resistance
por: Kasozi, Keneth Iceland, et al.
Publicado: (2022)

Cervical collars and immobilisation: A South African best practice recommendation
por: Stanton, D., et al.
Publicado: (2017)

Systematic Review and Meta-Analysis on Human African Trypanocide Resistance
por: Kasozi, Keneth Iceland, et al.
Publicado: (2022)

Seroepidemiologic Survey of Crimean-Congo Hemorrhagic Fever Virus in Selected Risk Groups, South Africa
por: Vawda, Sabeehah, et al.
Publicado: (2018)

Rapid emergence of resistance to antiretroviral treatment after undisclosed prior exposure: A case report
por: Rossouw, Theresa M., et al.
Publicado: (2019)

Variation in HIV care and treatment outcomes by facility in South Africa, 2011–2015: A cohort study
por: Bor, Jacob, et al.
Publicado: (2021)

Nephroblastoma - A 25-year review of a South African unit
por: Visser, YT, et al.
Publicado: (2014)

It is time to consider third-line options in antiretroviral-experienced paediatric patients?
por: van Zyl, Gert U, et al.
Publicado: (2011)

Delays in repeat HIV viral load testing for those with elevated viral loads: a national perspective from South Africa
por: Fox, Matthew P, et al.
Publicado: (2020)

Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa
por: Jooste, Pieter, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8mkdm7gh1p9ap2mk3kdgat4ifq